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Tuberculosis (TB) control remains an important public health priority for Bulgaria. The pop-
ulation structure of Mycobacterium tuberculosis is clonal and certain genetic families of this
species (e.g., Latin-American-Mediterranean [LAM]) have attracted more attention due to
their global dissemination and/or particular pathogenic properties, e.g., association with
multidrug resistance (MDR). The aim of this study was to evaluate the prevalence of the
M. tuberculosis LAM family in Bulgaria based on the use of different molecular markers.
A total of 101 previously spoligotyped M. tuberculosis strains were studied by LAM-
specific PCR assay to detect an insertion of IS6110 in the specific genome region. On the
whole, clear-cut results were obtained for most strains; spoligotype-based family was reas-
signed in some of them. At the same time, double bands were amplified in some cases and
warrant further validation studies of this method. The higher MDR rate among LAM versus
other genotype isolates was observed (P = 0.04). In conclusion, these results suggest a low
(<4%) prevalence rate of LAM in Bulgaria (that is similar to its Balkan neighbors) and high-
light the importance of using robust markers for correct detection of the LAM family.
 2015 Asian African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.Introduction
Tuberculosis (TB) remains an important public health issue in
Bulgaria. Although the number of new cases has declined
since 2006 (41/100,000), the TB incidence rate in Bulgaria is
still sufficiently high (26.7/100,000 in 2013), as well as
multidrug-resistant TB (MDR-TB) rates among new TB cases
(5.8%). Clinical and epidemiological characterization of themajor Mycobacterium tuberculosis (M. tuberculosis) subpopula-
tions circulating in different geographic regions is an essen-
tial step for developing better diagnostics, therapeutics, and
vaccines. The integration of molecular analysis of M. tubercu-
losis with an epidemiological analysis of clinical information
provides a new tool to assess possible associations between
M. tuberculosis strain types and the clinical and epidemiologi-
cal characteristics of the disease [1]., Bulgaria
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certain genetic families of this species have attracted more
attention due to their global dissemination and/or pathogenic
properties. A number of studies demonstrated an association
with drug resistance of the Latin-American-Mediterranean
(LAM) family [2–4]. On the other hand, other studies have
shown high transmissibility of this strain, but not a signifi-
cant association with increased virulence [5,6]. LAM was ini-
tially suggested by analysis of the global spoligotyping
dataset [7] and its spoligotyping signature is absence of sig-
nals 21–24 and 33–36 (Fig. 1). However, abridged spoligopro-
files with long blocks of deleted spacers (e.g., SIT125) or
homoplasy spoligoprofiles (e.g., SIT803) make identification
of such isolates uncertain [8–10]. To solve a phylogenetic
ambiguity, the use of other molecular markers/methods
may be helpful, in particular, MIRU-VNTR cluster analysis
using reference LAM isolates (e.g., using MIRU-VNTRplus.
org) or use of phylogenetically robust SNPs [11,12]. An
IS6110 insertion in the specific genome region between genes
lpqQ and Rv0836c (coding for hypothetical proteins) has also
been suggested for detection of LAM [13,14] (Fig. 2) and evalu-
ated in the present study.
Correct detection of the LAM family of M. tuberculosis has
both phylogenetic and practical interest. The aim of this
study was to evaluate the prevalence of LAM among M. tuber-
culosis strains circulating in Bulgaria based on the use of dif-
ferent molecular markers.
Materials and Methods
A study sample included 101 M. tuberculosis isolates obtained
from different regions of the country and previously charac-
terized by spoligotyping and other methods [15]. The DNA
of the studied strains was extracted from 4 to 6 weeks
Lo¨wenstein–Jensen medium culture using the recommended
method [16]. Spoligotyping was performed as described previ-
ously [17]. The individual spoligotyping patterns were com-
pared with the international database SITVIT2 (Institut
Pasteur de Guadeloupe) that is an updated version of the pub-
lished SITVIT_WEB database [18].
Analysis of the IS6110 element specific for the LAM genetic
family was performed as described previously [14]. In brief, a
205-bp band indicates a LAM strain due to the presence of an
IS6110 element in a specific site in the genome, whereas a
141-bp band indicates a non-LAM strain lacking the IS6110
element in this site (Fig. 3).
To minimize the risk of laboratory cross-contamination
during PCR amplification, each procedure (preparation of
the PCR mixes, the addition of the DNA, the PCR amplifica-
tion, and the electrophoretic fractionation) was conductedFig. 1 – Visual presentation of the decision rules for definition o
spoligotypes.in physically separated rooms. Negative controls (water) were
included to control for reagent contamination.
A 2 · 2 v2 test was used to detect any significant difference
between the two groups. Yates corrected v2 and P-values were
calculated with 95% confidence interval at http://www.med-
calc.org/calc/odds_ratio.php online resource.
Results and discussion
Application of the published rules for the definition of the
major spoligotype clades and comparison with SITVIT2 global
database permitted the assignment of most of the strains to
the known spoligotype families. At the same time, some types
were assigned to the convergent family (e.g., LAM/S) and use
of further methods would be required. The PCR approach was
used to define the LAM family [14] and all strains were tested
for the presence or absence of the LAM-specific IS6110
insertion (Fig. 3; Table S1). Comparison of results obtained
by different methods is shown in Table S1 where the spoligo-
profiles are sorted for easier visualization of data. This per-
mitted the identification of 3 differently sized groups of
strains. The first group included 11 strains with 2 amplified
bands. The multiplex PCR targeted an insertion of IS6110 in
the specific genome region and was designed in such a way
that either one of the other bands are amplified in case of
the presence or absence of such insertion. Hence, these 11
strains present an apparent discrepancy. A double band is
apriori impossible since this genome target appears to be
unique. Only one of these strains was assigned to LAM in
SITVIT_WEB (strain 54, SIT1280, although it was labeled as
LAM/S in the previous version SpolDB4). Other strains with
a double band belonged to T, X, Haarlem and unknown
families; neither had a LAM-specific deletion block in the
spoligoprofile (deleted signals 21–24). Furthermore, in 4
strains both bands were equally strong, thus excluding a pos-
sibility of contamination. 24-loci VNTR typing presented an
additional proof of the lack of technical error (contamination):
no strains had multiple alleles (not shown). An amplification
of the additional band may be specific but not related to
the targeted genome region. Further study of these cases is
warranted.
The second group included 86 strains with a single ampli-
fied band, specific for the absence of the IS6110 insertion in
the target locus, hence indicative of other than the LAM fam-
ily (Table S1). Few observations can be made regarding the
discrepancies with spoligotype-defined families. Four of the
studied strains belonged to SIT41 defined in SITVIT_WEB as
LAM7-TUR. However, no LAM-specific band was amplified in
these strains; hence they cannot be defined as LAM. Indeed,
another online resource for M. tuberculosis molecular typingf the LAM and S spoligotype families and ambiguous
Fig. 2 – Specific IS6110 insertion characteristic of the LAM family. Complete genomes of M. tuberculosis strains were retrieved
from GenBank and aligned using Mauve 2.3.1 program (http://darlinglab.org/mauve/mauve.html).
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TUR, based on the analysis of different molecular markers,
including VNTRs and SNPs. It is also interesting to note that
all studied strains of the SIT125, which had an uncertain fam-
ily definition (LAM/S in earlier SpolDB4 and T2/LAM3 in
SITVIT_WEB), did not have a LAM-specific band; hence their
family status cannot be LAM. Finally, two strains of SIT1588
had a single non-LAM band which is intriguing, since these
strains had a prototype LAM signature (see SIT42 in Fig. 1),
in addition to the deleted first signals. This profile may be a
result of the convergent evolution of the DR locus, and more
strains of this spoligotype SIT1588 should be studied in order
to verify its family status.
Regarding the third and smallest group of strains, it
included 4 strains with only LAM-specific band amplified.
One of them–strain 52–was assigned to LAM in SITVIT_WEB;
strain 8 was assigned to T5-RUS1, but it was recently shown
to belong to LAM [9]. In its turn, strain 126 (‘new’ spoligotype,
‘unknown’ family in SITVIT_WEB) may indeed belong to LAM
as confirmed herein by LAM-PCR. At the same time, strain 81
(SIT453/T) had LAM-specific band amplified, but intactspacers 21–24; this discrepancy is unexpected and questions
the value of this IS6110-PCR as LAM-specific.
The importance of the correct detection of LAM is
explained by the fact that the heterogeneous genetic family
ofM. tuberculosis, LAM, has been shown in geographically dis-
tant settings to demonstrate remarkable pathogenic features.
First, in Brazil, RD-Rio sublineage of LAM accounts for 37% of
the total TB burden and was shown to be associated with pul-
monary cavitation. Since cavitary TB is associated with a
higher sputum-bacillary load, this finding supports the
hypothesis that RD-Rio M. tuberculosis is associated with a
more ‘‘severe’’ disease as a strategy to increase transmission,
at least in some ethnic groups [5]. Secondly, LAM-RUS sublin-
eage in central Russia (along with the Beijing genotype) was
shown to be associated with MDR and clustering: the level
of drug resistance in new cases was almost twice as high as
the estimated average national level [2]. In the present study,
2 of the 4 isolates with a single LAM-specific PCR fragment
were MDR, while two others were susceptible. Regarding 97
non-LAM isolates, 71 of them were susceptible and 10 were
MDR. However, the higher MDR rate among LAM versus other
Fig. 3 – LAM-specific PCR: (a) schematic view of the genome region harboring LAM-specific IS6110 insertion in complete
genome of strain F11. Three primers (arrows) are used in one reaction: LAM-F, LAM-R, XhoI. Non-LAM strain (without this
IS6110-insertion): primers LAM-R and LAM-F amplify 141 bp fragment. LAM strain (with this IS6110 insertion): primers LAM-
R and XhoI amplify 205 bp fragment (b) gel-electrophoresis. Lane 4 – LAM strain; lanes 8–9: mixed profile. M, molecular
weights marker ‘‘100 bp DNA ladder’’ (GE Healthcare).
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caution due to the very small sample size of the LAM group,
and further study is warranted.
Geographically, the 4 confirmed LAM isolates were not
evenly dispersed across Bulgaria, but rather represented
northern (Vratsa, Veliko Tarnovo and Pleven) and western
(Sofia) parts of the country. Further placing these results in
the wider regional context permitted this study to reveal an
intriguing gradient of the LAM prevalence. Data on some
countries are absent or scarce and estimations based only
on spoligotypes are uncertain. These estimations were
obtained keeping in mind that: (i) SIT4 cannot be assigned
to any family based on spoligotyping alone; and (ii) LAM-
TUR and LAM-CAM do not belong to LAM, but rather repre-
sent separate families within the Euro-American lineage. It
appears that similar to Bulgaria (4%), the LAM rate is low/neg-
ligible in other Balkan countries: Turkey – 3.4%; Greece – 1–4%;
Romania – 0% (SITVIT_WEB); and Albania – 0% [19]. In con-
trast, the LAM rate is higher in the northeastern neighbors
of Bulgaria beyond the Balkans, reaching 17% in Southern
Ukraine [20], 25%-39% in European Russia, and 42% in
Belarus [9]. In its turn, this situation correlates with the preva-
lence of the rare Bulgarian LAM isolates mainly in the north-
ern part of the country.
In conclusion, application of the LAM-specific PCR revealed
a low (3%-4%depending on themarker used) prevalence rate of
LAM family in the M. tuberculosis population in this country.
Compared with spoligotyping, a phylogenetic family of 38
strains was revised or questioned: 27 strains were shown not
to belong to LAM,while 11more strains showedapparentlydis-
crepant results. This situation questions the global utility of
such PCR and highlights the importance of using multiple
markers for the molecular detection of the LAM family.
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